PF-07059013: A Noncovalent Modulator of Hemoglobin for Treatment of Sickle Cell Disease
Ariamala Gopalsamy, Ann Aulabaugh, Amey Barakat, Kevin Beaumont, Shawn Cabral, Daniel P. Canterbury, Agustin Casimiro‐Garcia, Jeanne S. Chang, Ming Z. Chen, Chulho Choi, Robert L. Dow, Olugbeminiyi Fadeyi, Xidong Feng, Scott P. France, Roger M. Howard, Jay M. Janz, J. Jasti, Reema Jasuja, Lyn H. Jones, Amanda King‐Ahmad, Kelly M. Knee, Jeffrey T. Kohrt, Chris Limberakis, Spiros Liras, Carlos A. Martínez, Kim F. McClure, Arjun Narayanan, Jatin Narula, Jonathan J. Novak, Thomas N. O’Connell, Mihir D. Parikh, David W. Piotrowski, Olga Plotnikova, Ralph P. Robinson, Parag V. Sahasrabudhe, Raman Sharma, Benjamin A. Thuma, Dipy M. Vasa, Liuqing Wei, Anne Wenzel, Jane M. Withka, Jun Xiao, Hatice G. Yayla
Abstract
(PF-07059013) has advanced to phase 1 clinical trials.